Breaking News

Theorem Expands Cardio Capabilities

By Kristin Brooks | January 7, 2014

Forms strategic alliance with BioTelemetry division

Theorem Clinical Research has entered a strategic alliance with BioTelemetry, Inc. and its clinical research division Cardiocore, a global cardiac core lab. Financial terms of the pact were not disclosed.
 
Discussing the alliance, John Potthoff, Theorem president and chief executive officer, remarked, “Theorem’s business strategy is to offer our clients the very best in every service area. BioTelemetry reinforces that strategy with a team of industry-leading scientists, a set of advanced technologies and a broad base of cardiac testing modalities. Theorem clients will benefit from BioTelemetry’s expert consulting services and deep experience across all major therapeutic areas.”
 
BioTelemetry’s chief executive officer, Joseph Capper, said, “Theorem’s experience in complex protocols aligns perfectly with our specialized cardiovascular testing services. The partnership complements BioTelemetry’s unique position that spans from clinical research through post-market surveillance and into clinical practice.  Both companies support trials in all clinical phases of pharmaceutical and biotech development and will collaborate globally within this alliance.”
blog comments powered by Disqus
  • CMO Systems

    CMO Systems

    Philip K. Burns, CRO Consulting||April 5, 2016
    A CMO system includes four aspects of the product lifecycle: regulatory, technical, compliance, and operations.

  • Injectables: The New Oral?

    Injectables: The New Oral?

    Tugrul Kararli, Kurt Sedo, Josef Bossart, PharmaCircle LLC||April 5, 2016
    The growth trend of injectables continues across the pharma landscape.

  • Biopharmaceutical Contract Manufacturing Contract Negotiations

    Biopharmaceutical Contract Manufacturing Contract Negotiations

    William Downey, HighTech Business Decisions||April 5, 2016
    Navigating the complexities of supply agreements.